title: Active site binding modes of HIV-1 integrase inhibitors.
abstract: Using the crystal structure of the first complex of the HIV-1 integrase catalytic core domain with an inhibitor bound to the active site, structural models for the interaction of various inhibitors with integrase were generated by computational docking. For the compound of the crystallographic study, binding modes unaffected by crystal packing have recently been proposed. Although a large search region was used for the docking simulations, the ligands investigated here are found to bind preferably in similar ways close to the active site. The binding site is formed by residues 64-67, 116, 148, 151-152, 155-156, and 159, as well as by residue 92 in case of the largest ligand of the series. The coherent picture of possible interactions of small-molecule inhibitors at the active site provides an improved basis for structure-based ligand design. The recurring motif of tight interaction with the two lysine residues 156 and 159 is suggested to be of prime importance.
authors.affiliation: Department of Chemistry and Biochemistry, Howard Hughes Medical Institute, University of California, San Diego, La Jolla, California 92093-0365, USA. csotriff@mccammon.ucsd.edu
authors.forename: C A
authors.initials: CA
authors.lastname: Sotriffer
authors.forename: H
authors.initials: H
authors.lastname: Ni
authors.forename: J A
authors.initials: JA
authors.lastname: McCammon
mesh_terms: D000880:Anthraquinones / Q000737:chemistry; D002109:Caffeic Acids; D020134:Catalytic Domain; D002396:Catechols / Q000737:chemistry; D015195:Drug Design; D019428:HIV Integrase Inhibitors / Q000737:chemistry*; D015497:HIV-1; D007211:Indoles / Q000737:chemistry; D008024:Ligands; D008958:Models, Molecular; D009282:Naphthalenesulfonates / Q000737:chemistry; D013141:Spiro Compounds / Q000737:chemistry; D013329:Structure-Activity Relationship; D013386:Succinates / Q000737:chemistry; D013777:Tetrazoles / Q000737:chemistry
chemical_list: C400757:1-(5-chloroindol-3-yl)-3-hydroxy-3-(2H-tetrazol-5-yl)propenone; C409871:3,3,3',3'-tetramethyl-1,1'-spirobi(indan)-5,5',6,6'-tetrol; D000880:Anthraquinones; D002109:Caffeic Acids; D002396:Catechols; D019428:HIV Integrase Inhibitors; D007211:Indoles; D008024:Ligands; D009282:Naphthalenesulfonates; D013141:Spiro Compounds; D013386:Succinates; D013777:Tetrazoles; C100435:chicoric acid